Literature DB >> 32747510

Appropriate Use Criteria for PET Myocardial Perfusion Imaging.

Thomas H Schindler1, Timothy M Bateman1, Daniel S Berman1, Panithaya Chareonthaitawee1,2, Lorraine E De Blanche3, Vasken Dilsizian1,2, Sharmila Dorbala1, Robert J Gropler1, Leslee Shaw4,5, Prem Soman1,4, David E Winchester6, Hein Verberne7, Sukhjeet Ahuja1, Rob S Beanlands1,2,4,8,9, Marcelo F Di Carli1,10, Venkatesh L Murthy1, Terrence D Ruddy1,8,9, Ronald G Schwartz1.   

Abstract

Mesh:

Year:  2020        PMID: 32747510     DOI: 10.2967/jnumed.120.246280

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


× No keyword cloud information.
  10 in total

Review 1.  Utility of nuclear cardiovascular imaging in the cardiac intensive care unit.

Authors:  Aldo L Schenone; Erika Hutt; Paul Cremer; Wael A Jaber
Journal:  J Nucl Cardiol       Date:  2021-06-09       Impact factor: 5.952

2.  Relationship Between Myocardial Perfusion Imaging Abnormalities on Positron Emission Tomography and Anginal Symptoms, Functional Status, and Quality of Life.

Authors:  Krishna K Patel; Femina S Patel; Timothy M Bateman; Kevin F Kennedy; Poghni A Peri-Okonny; A Iain McGhie; Brett W Sperry; Leslee Shaw; Marcelo Di Carli; Randall C Thompson; Ibrahim M Saeed; Philip G Jones; John A Spertus
Journal:  Circ Cardiovasc Imaging       Date:  2022-02-15       Impact factor: 7.792

3.  Role of Exercise Treadmill Testing in the Assessment of Coronary Microvascular Disease.

Authors:  Diana M Lopez; Sanjay Divakaran; Ankur Gupta; Navkaranbir S Bajaj; Michael T Osborne; Wunan Zhou; Jon Hainer; Courtney F Bibbo; Hicham Skali; Sharmila Dorbala; Viviany R Taqueti; Ron Blankstein; Marcelo F Di Carli
Journal:  JACC Cardiovasc Imaging       Date:  2021-08-18

4.  Hot spot imaging in cardiovascular diseases: an information statement from SNMMI, ASNC, and EANM.

Authors:  Brett W Sperry; Timothy M Bateman; Esma A Akin; Paco E Bravo; Wengen Chen; Vasken Dilsizian; Fabien Hyafil; Yiu Ming Khor; Robert J H Miller; Riemer H J A Slart; Piotr Slomka; Hein Verberne; Edward J Miller; Chi Liu
Journal:  J Nucl Cardiol       Date:  2022-07-21       Impact factor: 3.872

5.  Prevalence and predictors of automatically quantified myocardial ischemia within a multicenter international registry.

Authors:  Donghee Han; Alan Rozanski; Robert J H Miller; Tali Sharir; Andrew J Einstein; Mathews B Fish; Terrence D Ruddy; Philipp A Kaufmann; Albert J Sinusas; Edward J Miller; Timothy M Bateman; Sharmila Dorbala; Marcelo Di Carli; Joanna X Liang; Damini Dey; Daniel S Berman; Piotr J Slomka
Journal:  J Nucl Cardiol       Date:  2022-02-16       Impact factor: 3.872

6.  BMIPP SPECT in cardiac sarcoidosis: A marker of risk?

Authors:  Roxana Campisi; María Fernanda Merani; Marina I Rodríguez
Journal:  J Nucl Cardiol       Date:  2021-04-26       Impact factor: 5.952

7.  Practical Guide for Interpreting and Reporting Cardiac PET Measurements of Myocardial Blood Flow: An Information Statement from the American Society of Nuclear Cardiology, and the Society of Nuclear Medicine and Molecular Imaging.

Authors:  Timothy M Bateman; Gary V Heller; Rob Beanlands; Dennis A Calnon; James Case; Rob deKemp; E Gordon DePuey; Marcelo Di Carli; Emel C Guler; Venkatesh L Murthy; Jeffrey Rosenblatt; Ronald Sher; Piotr Slomka; Terrence D Ruddy
Journal:  J Nucl Med       Date:  2021-03-31       Impact factor: 11.082

8.  Impact of rubidium imaging availability on management of patients with acute chest pain.

Authors:  Akasha Shaukat Ali; Vincent Finnerty; Francois Harel; Guillaume Marquis-Gravel; Alain Vadeboncoeur; Matthieu Pelletier-Galarneau
Journal:  J Nucl Cardiol       Date:  2022-02-23       Impact factor: 5.952

Review 9.  Regulatory Agencies and PET/CT Imaging in the Clinic.

Authors:  Peter Herscovitch
Journal:  Curr Cardiol Rep       Date:  2022-08-01       Impact factor: 3.955

10.  Post COVID-19 syndrome with impairment of flow-mediated epicardial vasodilation and flow reserve.

Authors:  Amanda Verma; Tarun Ramayya; Anand Upadhyaya; Ines Valenta; Maureen Lyons; Jonas Marschall; Farrokh Dehdashti; Robert J Gropler; Pamela K Woodard; Thomas Hellmut Schindler
Journal:  Eur J Clin Invest       Date:  2022-09-09       Impact factor: 5.722

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.